4519

JPX:4519

CHUGAI PHARMACEUTICAL CO., LTD.

  • Stock

JPY

Last Close

8,439.00

02/05 06:30

Market Cap

10.45T

Beta: 0.50

Volume Today

4.16M

Avg: 2.29M

PE Ratio

25.03

PFCF: 44.22

Dividend Yield

1.56%

Payout:39.09%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
134.05B
-
150.35B
12.16%
173.29B
15.25%
177.25B
2.29%
164.21B
7.36%
163.74B
0.28%
176.01B
7.49%
196.37B
11.57%
250.52B
27.58%
282.84B
12.90%
average payables
61.12B
-
70.52B
15.39%
75.35B
6.84%
67.93B
9.84%
67.61B
0.47%
74.67B
10.44%
89.02B
19.21%
126.33B
41.92%
181.05B
43.31%
161.15B
10.99%
average receivables
144.14B
-
159.30B
10.52%
163.10B
2.38%
171.24B
4.99%
177.28B
3.53%
180.60B
1.87%
217.50B
20.43%
304.68B
40.09%
435.15B
42.82%
417.32B
4.10%
book value per share
364.55
-
382.24
4.85%
393.95
3.06%
422.00
7.12%
460.29
9.07%
520.04
12.98%
596.31
14.67%
722.59
21.18%
865.98
19.84%
987.89
14.08%
capex per share
-11.72
-
-15.43
31.63%
-22.23
44.06%
-27.16
22.17%
-47.30
74.17%
-37.25
21.24%
-37.37
0.30%
-44.32
18.60%
-43.31
2.28%
-45.13
4.20%
capex to depreciation
-1.29
-
-1.62
25.99%
-2.23
37.11%
-2.73
22.51%
-2.34
-
capex to operating cash flow
-0.52
-
-0.40
22.42%
-0.94
133.87%
-0.41
55.94%
-0.65
57.66%
-0.30
54.61%
-0.30
1.17%
-0.26
13.00%
-0.29
11.99%
-0.18
38.14%
capex to revenue
-0.04
-
-0.05
21.84%
-0.07
46.24%
-0.08
12.54%
-0.13
60.72%
-0.09
33.45%
-0.08
12.47%
-0.07
6.60%
-0.06
22.42%
-0.07
18.17%
cash per share
140.70
-
144.21
2.50%
125.44
13.02%
148.26
18.19%
151.87
2.43%
202.82
33.55%
230.38
13.59%
287.07
24.60%
305.87
6.55%
449.09
46.82%
days of inventory on hand
233.60
-
244.82
4.80%
272.99
11.51%
242.77
11.07%
221.29
8.85%
230.63
4.22%
245.45
6.42%
225.42
8.16%
223.95
0.65%
241.52
7.85%
days payables outstanding
104.93
-
119.04
13.45%
106.50
10.54%
91.21
14.35%
99.57
9.16%
106.50
6.96%
134.00
25.82%
164.36
22.65%
160.82
2.15%
99.32
38.24%
days sales outstanding
126.56
-
116.13
8.24%
124.31
7.04%
119.57
3.81%
113.04
5.46%
96.62
14.53%
117.51
21.62%
129.97
10.61%
148.99
14.63%
105.21
29.38%
debt to assets
0.00
-
0.00
222.58%
0.00
14.30%
0.00
50.73%
0.00
40.68%
debt to equity
0.00
-
0.00
227.13%
0.00
14.92%
0.00
51.40%
0.00
41.42%
dividend yield
0.02
-
0.01
19.21%
0.02
40.98%
0.01
44.87%
0.01
5.19%
0.01
1.91%
0.01
1.03%
0.02
58.87%
0.02
55.32%
0.01
40.00%
earnings yield
0.03
-
0.03
16.29%
0.03
10.72%
0.02
21.16%
0.03
14.86%
0.03
7.83%
0.02
16.85%
0.05
107.81%
0.07
36.98%
0.04
45.22%
enterprise value
1.50T
-
2.21T
47.37%
1.74T
21.48%
3.01T
73.49%
3.35T
10.97%
5.31T
58.82%
8.83T
66.20%
5.87T
33.50%
5.32T
9.46%
8.33T
56.68%
enterprise value over ebitda
19.71
-
25.34
28.53%
23.31
7.99%
31.04
33.12%
27.52
11.32%
25.54
7.19%
29.61
15.92%
14.00
52.71%
10.01
28.51%
18.83
88.16%
ev to operating cash flow
40.55
-
35.17
13.26%
44.80
27.37%
28.01
37.47%
28.10
0.30%
25.71
8.48%
43.07
67.51%
21.00
51.24%
21.78
3.72%
20.26
7.01%
ev to sales
3.26
-
4.44
36.22%
3.53
20.35%
5.64
59.72%
5.77
2.25%
7.74
34.20%
11.22
44.92%
5.87
47.65%
4.22
28.15%
7.50
77.63%
free cash flow per share
10.93
-
23.00
110.47%
1.44
93.72%
38.48
2,566.20%
25.21
34.48%
88.58
251.34%
87.39
1.34%
125.76
43.90%
105.10
16.43%
204.84
94.90%
free cash flow yield
0.01
-
0.02
47.13%
0.00
92.07%
0.02
1,450.27%
0.01
40.75%
0.03
122.37%
0.02
39.76%
0.03
112.02%
0.03
7.32%
0.04
22.88%
graham net net
170.00
-
168.32
0.99%
161.17
4.25%
182.54
13.26%
183.13
0.32%
212.17
15.86%
246.49
16.17%
299.69
21.58%
358.43
19.60%
491.65
37.17%
graham number
505.69
-
566.64
12.05%
538.44
4.98%
648.91
20.52%
763.74
17.70%
1.06K
38.73%
1.32K
24.96%
1.73K
30.73%
2.11K
21.67%
2.10K
0.44%
income quality
0.37
-
0.57
52.76%
0.38
33.94%
0.86
128.60%
0.78
9.09%
0.83
5.62%
0.60
27.24%
0.59
1.35%
0.42
28.69%
1.26
198.13%
intangibles to total assets
0.02
-
0.02
12.44%
0.02
39.49%
0.02
3.30%
0.02
0.16%
0.02
9.94%
0.02
13.05%
0.01
26.11%
0.01
5.85%
0.01
23.57%
interest coverage
6.90K
-
1.30K
81.22%
894
30.98%
899.40
0.60%
1.12K
24.53%
1.68K
50.42%
4.86K
188.38%
8.79K
80.91%
8.74K
0.53%
15.21K
73.95%
interest debt per share
0.14
-
0.49
255.98%
0.45
8.92%
0.27
39.03%
0.20
27.02%
0.08
61.66%
0.04
50.44%
0.03
22.61%
0.04
27.03%
0.02
55.76%
inventory turnover
1.56
-
1.49
4.58%
1.34
10.32%
1.50
12.45%
1.65
9.71%
1.58
4.05%
1.49
6.04%
1.62
8.88%
1.63
0.66%
1.51
7.27%
invested capital
0.00
-
0.00
227.13%
0.00
14.92%
0.00
51.40%
0.00
41.42%
market cap
1.62T
-
2.31T
43.24%
1.83T
20.81%
3.15T
72.10%
3.49T
10.74%
5.52T
57.99%
9.04T
63.91%
6.14T
32.10%
5.54T
9.79%
8.79T
58.68%
net current asset value
397.12B
-
407.64B
2.65%
418.97B
2.78%
439.56B
4.92%
437.07B
0.57%
494.75B
13.20%
579.41B
17.11%
712.98B
23.05%
891.17B
24.99%
1.06T
18.88%
net debt to ebitda
-1.49
-
-1.16
22.63%
-1.27
9.93%
-1.43
12.38%
-1.21
15.53%
-0.98
18.73%
-0.71
27.38%
-0.64
10.33%
-0.42
34.49%
-1.04
147.93%
net income per share
31.18
-
37.33
19.74%
32.71
12.39%
44.35
35.59%
56.32
27.00%
95.95
70.36%
130.66
36.18%
184.29
41.05%
227.64
23.52%
197.80
13.11%
operating cash flow per share
22.65
-
38.43
69.67%
23.67
38.40%
65.64
177.29%
72.51
10.47%
125.84
73.54%
124.76
0.86%
170.08
36.32%
148.41
12.74%
249.97
68.43%
payables turnover
3.48
-
3.07
11.85%
3.43
11.78%
4.00
16.76%
3.67
8.40%
3.43
6.50%
2.72
20.52%
2.22
18.47%
2.27
2.20%
3.67
61.91%
receivables turnover
2.88
-
3.14
8.98%
2.94
6.57%
3.05
3.96%
3.23
5.78%
3.78
16.99%
3.11
17.78%
2.81
9.59%
2.45
12.76%
3.47
41.61%
research and ddevelopement to revenue
0.18
-
0.17
4.13%
0.17
2.90%
0.17
0.65%
0.17
1.66%
0.16
8.06%
0.15
4.80%
0.14
8.30%
0.12
13.53%
0.16
32.49%
return on tangible assets
0.07
-
0.08
12.83%
0.07
13.78%
0.09
28.43%
0.10
17.91%
0.15
47.56%
0.18
16.46%
0.20
12.72%
0.20
1.61%
0.17
16.17%
revenue per share
282.00
-
304.67
8.04%
300.13
1.49%
325.81
8.55%
353.07
8.37%
417.86
18.35%
478.84
14.59%
608.08
26.99%
766.00
25.97%
675.40
11.83%
roe
0.09
-
0.10
14.20%
0.08
14.99%
0.11
26.58%
0.12
16.44%
0.18
50.78%
0.22
18.76%
0.26
16.40%
0.26
3.07%
0.20
23.83%
roic
0.09
-
0.10
13.76%
0.09
12.18%
0.11
24.64%
0.13
16.34%
0.19
48.31%
0.22
18.43%
0.26
15.91%
0.26
2.87%
0.19
29.82%
sales general and administrative to revenue
0.03
-
0.03
16.57%
0.02
6.52%
0.03
16.08%
0.03
18.33%
0.04
4.56%
0.03
22.01%
0.03
6.83%
0.02
27.45%
shareholders equity per share
364.55
-
382.24
4.85%
393.95
3.06%
422.00
7.12%
460.29
9.07%
520.04
12.98%
596.31
14.67%
722.59
21.18%
865.98
19.84%
987.89
14.08%
stock based compensation to revenue
tangible asset value
586.47B
-
613.76B
4.65%
627.20B
2.19%
671.82B
7.11%
733.83B
9.23%
830.45B
13.17%
956.12B
15.13%
1.17T
21.96%
1.40T
20.00%
1.61T
14.76%
tangible book value per share
358.66
-
374.86
4.52%
382.78
2.11%
409.74
7.04%
446.87
9.06%
505.71
13.17%
581.78
15.04%
709.22
21.91%
850.69
19.95%
975.83
14.71%
working capital
424.55B
-
434.71B
2.39%
455.10B
4.69%
476.24B
4.64%
464.88B
2.39%
520.41B
11.95%
598.84B
15.07%
736.24B
22.95%
912.81B
23.98%
1.08T
18.12%

All numbers in JPY (except ratios and percentages)